APA (7th ed.) Citation

AV, O., C, C., M, B., Y, T., V, D., O, R., . . . JC, N. (2026). Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma. JHEP reports : innovation in hepatology, 101915. https://doi.org/10.1016/j.jhepr.2026.101915

Chicago Style (17th ed.) Citation

AV, Odent, et al. "Clinical Predictors of Response to Atezolizumab-bevacizumab in Child-Pugh B Patients with Hepatocellular Carcinoma." JHEP Reports : Innovation in Hepatology 2026: 101915. https://doi.org/10.1016/j.jhepr.2026.101915.

MLA (9th ed.) Citation

AV, Odent, et al. "Clinical Predictors of Response to Atezolizumab-bevacizumab in Child-Pugh B Patients with Hepatocellular Carcinoma." JHEP Reports : Innovation in Hepatology, 2026, p. 101915, https://doi.org/10.1016/j.jhepr.2026.101915.